2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Aringer, Martin, Costenbader, Karen, Daikh, David, Brinks, Ralph, Mosca, Marta, Ramsey‐Goldman, Rosalind, Smolen, Josef S., Wofsy, David +56 more·2019·Arthritis & Rheumatology
DOI 10.1002/art.40930

Cited by (1,003)

Items 201–300 of 1,003

  1. Performance of 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in a paediatric population—a multicentre study
    Yoel Levinsky, Mor Broide, Shelly Kagan, Ori Goldberg, Oded Scheuerman, Rotem Tal, Irit Tirosh, Yoni Butbul, Daniel E. Furst, Liora Harel et al. · 2021 · Rheumatology
  2. Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease
    Jacy Zanussi, Juan Zhao, Wei‐Qi Wei, Gul Karakoc, Cecilia P. Chung, QiPing Feng, Nancy J. Olsen, C. Michael Stein, Vivian K. Kawai · 2023 · BMC Rheumatology
  3. Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition
    Hirokazu Kashiwagi, Masataka Kuwana, Mitsuru Murata, Naoki Shimada, Toshiro Takafuta, Jun Yamanouchi, Hisashi Kato, Takaaki Hato, Yoshiaki Tomiyama · 2023 · International Journal of Hematology
  4. Human‐multimodal deep learning collaboration in ‘precise’ diagnosis of lupus erythematosus subtypes and similar skin diseases
    Qianwen Li, Zhi Chun Yang, Kaili Chen, Ming Zhao, Hai Long, Yueming Deng, Haoran Hu, Jia Chen, Mei-Yu Wu, Zhidan Zhao et al. · 2024 · Journal of the European Academy of Dermatology and Venereology
  5. Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosis
    Hiroshi Shimagami, Kei Nishimura, Hiroaki Matsushita, Shoichi Metsugi, Yasuhiro Kato, Takahiro Kawasaki, Kohei Tsujimoto, Ryuya Edahiro, Eri Itotagawa, Maiko Naito et al. · 2025 · Nature Communications
  6. Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab
    Marla Guzman, Joyce S Hui‐Yuen · 2020 · Drug Design Development and Therapy
  7. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction
    Sara K. Tedeschi, Tristan Pascart, Augustin Latourte, Cattleya Godsave, Burak Kundakci, Raymond P. Naden, William John Taylor, Nicola Dalbeth, Tuhina Neogi, Fernando Pérez-Ruiz et al. · 2021 · Arthritis Care & Research
  8. Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
    Yinli Gui, Wei Bai, Jian Xu, Xinwang Duan, Feng Zhan, Chen Zhao, Zhenyu Jiang, Zhijun Li, Lijun Wu, Shengyun Liu et al. · 2022 · Chinese Medical Journal
  9. Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways
    Georgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, Dimitra Nikoleri, Nikolaos Malissovas, Myrto Nikoloudaki, Eirini-Maria Stergioti, Styliani Polia, Nikolaos Paschalidis, Anastasia Filia et al. · 2024 · Annals of the Rheumatic Diseases
  10. The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort
    Laura Durcan, Michelle Petri · 2020 · Seminars in Arthritis and Rheumatism
  11. Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases
    Xuan Yao, Megat Abd Hamid, Anand Sundaralingam, Alice C. Evans, Roshan Karthikappallil, Tao Dong, Najib Mahboob Rahman, Nikolaos I. Kanellakis · 2020 · Breathe
  12. New-Onset Systemic Lupus Erythematosus after mRNA SARS-CoV-2 Vaccination
    Laisha Báez-Negrón, Luis M. Vilá · 2022 · Case Reports in Rheumatology
  13. Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms
    Amanda M. Eudy, Jennifer L Rogers, Amy L. Corneli, Kevin McKenna, Mithu Maheswaranathan, David S. Pisetsky, Lisa G. Criscione‐Schreiber, Jayanth Doss, Rebecca E. Sadun, Kai Sun et al. · 2022 · Lupus Science & Medicine
  14. Current views on lupus in children
    Eve M D Smith, Hanna Lythgoe, Christian Michael Hedrich · 2022 · Current Opinion in Rheumatology
  15. Lupus Nephritis: Current Perspectives and Moving Forward
    Julia Lichtnekert, Hans‐Joachim Anders, Maciej Lech · 2022 · Journal of Inflammation Research
  16. Circadian rhythm in systemic autoimmune conditions: Potential of chrono-immunology in clinical practice: A narrative review
    Wireko Andrew Awuah, Helen Ye Rim Huang, Jacob B. Kalmanovich, Aashna Mehta, Tatiana Mikhailova, Jyi Cheng Ng, Toufik Abdul‐Rahman, Favour Tope Adebusoye, Joecelyn Kirani Tan, Karl Kamanousa et al. · 2023 · Medicine
  17. A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis
    Beatriz Frade‐Sosa, Javier Narváez, Tarek Carlos Salman-Monte, Raúl Castellanos‐Moreira, Vera Ortiz-Santamaría, Vicenç Torrente-Segarra, Ivan Castellvi, Berta Magallares, Dèlia Reina, Sónia Mínguez et al. · 2020 · Lupus
  18. Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus
    Becker, Yann L. C., Gagné, Jean‐Philippe, Julien, Anne‐Sophie, Lévesque, Tania, Allaeys, Isabelle, Gougeard, Nadine, Rubio, Vicente, Boisvert, François‐Michel, Jean, Dominique, Wagner, Eric et al. · 2022 · Arthritis & Rheumatology
  19. Association between serum antinuclear antibody and rheumatoid arthritis
    Fang Liu, Xiuqin Wang, Jianwen Zou, Ming Li, Cui-Cui Pan, Yuanquan Si · 2024 · Frontiers in Immunology
  20. Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease
    Fadi Kharouf, Qixuan Li, Laura P Whittall Garcia, Arenn Jauhal, D. Gladman, Zahi Touma · 2024 · Lara D. Veeken
  21. Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus erythematosus and antiphospholipid syndrome
    Eleonora Friedberg, Philipp Wohlfarth, Ana Iris Schiefer, Cathrin Skrabs, Winfried Franz Pickl, Nina Worel, Philipp Bernhard Staber, Ulrich Jaeger, Cihan Ay · 2024 · Journal of Thrombosis and Haemostasis
  22. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma
    Asim Kichloo, Michael M. Aljadah, Michael Stanley Albosta, Farah Wani, Jagmeet Singh, Shantanu Solanki · 2020 · Journal of Investigative Medicine High Impact Case Reports
  23. Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus
    James Greenan-Barrett, Georgia Doolan, Devina Shah, Simrun Virdee, George Robinson, Varvara Choida, Nataliya Gak, Nina M. de Gruijter, Elizabeth C. Rosser, Muthana Al Obaidi et al. · 2021 · International Journal of Molecular Sciences
  24. Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus
    Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Akio Kawabe, Yoshino Inoue, Naoaki Okubo, Shigeru Iwata, Kentaro Hanami, Yoshiya Tanaka · 2021 · Rheumatology
  25. Long-term outcomes of patients with systemic lupus erythematosus: A Multicenter Cohort Study from CSTAR registry
    Ziqian Wang, Mengtao Li, Zhizhong Ye, Caifeng Li, Zhijun Li, Xiang-Pei Li, Lijun Wu, Shengyun Liu, Xiaoxia Zuo, Ping Zhu et al. · 2021 · Rheumatology and Immunology Research
  26. Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype
    Erika Huijser, Cornelia G van Helden-Meeuwsen, Dwin G.B. Grashof, Jessica R. Tarn, Zana Brkić, Josje M.A. Huisman, Mohamed Javad Wahadat, Harmen J.G. van de Werken, Ana P. Lopes, Joël A. G. van Roon et al. · 2022 · Frontiers in Immunology
  27. Autoimmunity to synovial extracellular matrix proteins in patients with postinfectious Lyme arthritis
    Korawit Kanjana, Klemen Strle, Robert B. Lochhead, Annalisa Pianta, Laura Marlene Mateyka, Qi Wang, Sheila L. Arvikar, David E. Kling, Cameron A. Deangelo, Lucy M. Curham et al. · 2023 · Journal of Clinical Investigation
  28. Reference Range of Hydroxychloroquine Blood Levels That Can Reduce Odds of Active Lupus and Prevent Flares
    Shivani Garg, Betty A Chewning, Paul R. Hutson, Brad C. Astor, Christie Michels Bartels · 2023 · Arthritis Care & Research
  29. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome
    Katrien M.J. Devreese · 2024 · International Journal of Laboratory Hematology
  30. The Chinese gut virus catalogue reveals gut virome diversity and disease-related viral signatures
    Qiulong Yan, Liansha Huang, Shenghui Li, Yue Zhang, Ruochun Guo, Pan Zhang, Zhixin Lei, Qingbo Lv, Fang Chen, Zhiming Li et al. · 2025 · Genome Medicine
  31. Utility of repeated antinuclear antibody tests: a retrospective database study
    Ai Li Yeo, Suong T. T. Le, Jason J. Ong, Kathryn Connelly, Samar Ojaimi, Hieu Tri Nim, Eric Francis Morand, Michelle T. Leech · 2020 · The Lancet Rheumatology
  32. Acute exacerbation in interstitial lung disease
    EsamH Alhamad, Joseph G. Cal, Nuha Nasser Alrajhi, AhmadA AlBoukai · 2021 · Annals of Thoracic Medicine
  33. Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
    Aigli G. Vakrakou, Dimitrios Tzanetakos, Maria‐Eleftheria Evangelopoulos, Theodore Argyrakos, John S. Tzartos, Maria C. Anagnostouli, Elissavet Andreadou, Georgios Koutsis, Georgios Velonakis, Panagiotis Toulas et al. · 2021 · Therapeutic Advances in Neurological Disorders
  34. Systemic Lupus Erythematosus and Pregnancy: a Portuguese Case–Control Study
    António Costa Braga, Tânia Barros, Raquel Faria, António Marinho, Guilherme Rocha, Fátima Farinha, Esmeralda Neves, Carlos Vasconcelos, Jorge Sousa Braga · 2021 · Clinical Reviews in Allergy & Immunology
  35. High titers of antinuclear antibody and the presence of multiple autoantibodies are highly suggestive of systemic lupus erythematosus
    Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin · 2022 · Scientific Reports
  36. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
    May Y. Choi, Ann Elaine Clarke, Murray B. Urowitz, John G. Hanly, Yvan St‐Pierre, Caroline Gordon, Sang‐Cheol Bae, Juanita Romero‐Díaz, Jorge Sánchez‐Guerrero, Sasha Bernatsky et al. · 2022 · Annals of the Rheumatic Diseases
  37. Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial
    Ho So, Evelyn Chow, Isaac T Cheng, Sze-Lok Lau, Tena K. Li, Cheuk‐Chun Szeto, Lai‐Shan Tam · 2022 · Lupus
  38. Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors
    Jing Cui, Susan Malspeis, May Y. Choi, Bing Lü, Jeffrey A. Sparks, Kazuki Yoshida, Karen H. Costenbader · 2022 · Seminars in Arthritis and Rheumatism
  39. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation
    Binshan Zhang, Guolan Xing · 2022 · Frontiers in Immunology
  40. CD169 expression on monocytes as a marker for assessing type I interferon status in pediatric inflammatory diseases
    Naoto Sakumura, Tadafumi Yokoyama, Masaaki Usami, Yuiko Hosono, Natsumi Inoue, Yusuke Matsuda, Yuko Tasaki, Taizo Wada · 2023 · Clinical Immunology
  41. EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO)
    Yongdong Zhao, Melissa S. Oliver, Anja Schnabel, Eveline Y. Wu, Zhaoyi Wang, Achille Marino, Cassyanne L. Aguiar, Jonathan D. Akikusa, Ümmüşen Kaya Akça, Beverley Almeida et al. · 2025 · Annals of the Rheumatic Diseases
  42. Autoantibodies in Systemic Lupus Erythematosus: Diagnostic and Pathogenic Insights
    Eleni Pagkopoulou, Charalampos Loutradis, Maria Papaioannou, Maria Daoudaki, Maria J. Stangou, Theodoros Dimitroulas · 2025 · Journal of Clinical Medicine
  43. Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus
    Alberto Morotti, Irena Sollaku, Simona Catalani, Franco Franceschini, Ilaria Cavazzana, Micaela Fredi, Emma Sala, Giuseppe De Palma · 2020 · Rheumatology
  44. Lupus erythematosus: Significance of dermatologic findings
    Cédric Lenormand, Dan M. Lipsker · 2021 · Annales de Dermatologie et de Vénéréologie
  45. Identification of circulating miR-22-3p and let-7a-5p as novel diagnostic biomarkers for rheumatoid arthritis
    Jifeng Tang, Junyu Lin, Ziqing Yu, Renquan Jiang, Jinfang Xia, Bin Yang, Qishui Ou, Jinpiao Lin · 2022 · Clinical and Experimental Rheumatology
  46. Pregnancy Outcomes in Systemic Lupus Erythematosus Women: A single tertiary centre experience
    Nihal M. Al-Riyami, Bushra Mustafa Salman, Amani Al-Rashdi, Tamima Al‐Dughaishi, Rahma Haddabi, Batool Hassan · 2021 · Sultan Qaboos University medical journal
  47. Self‐concept and body image of people living with lupus: A systematic review
    Larissa Rodrigues, Margarida Sim-Sim, Luís Sousa, Débora Bicudo Faria-Schützer, Fernanda Garanhani Surita · 2021 · International Journal of Rheumatic Diseases
  48. Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review
    Shirin Assar, Mehran Pournazari, Parviz Soufivand, Dena Mohamadzadeh · 2021 · The Egyptian Rheumatologist
  49. A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus
    Xin Huang, Qing Zhang, Huilin Zhang, Qianjin Lu · 2022 · Clinical Reviews in Allergy & Immunology
  50. A glimpse into the future of systemic lupus erythematosus
    Martin Aringer, Marta Eugenia Alarcón-Riquelme, Megan E. B. Clowse, Guillermo J. Pons-Estel, Edward M J Vital, Maria Dall’Era · 2022 · Therapeutic Advances in Musculoskeletal Disease
  51. Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis
    Theerada Assawasaksakul, Seelwan Sathitratanacheewin, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Yingyos Avihingsanon, Nawaporn Assawasaksakul, Wonngarm Kittanamongkolchai · 2022 · Lupus Science & Medicine
  52. Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study
    Dahai Wang, Chunrong Shan, Jia Liu, Ranran Zhang, Guohao Zhu, Tingting Gao, Hong Chang, Shan Gao, Cui Bai, Nana Nie et al. · 2022 · Frontiers in Immunology
  53. Lupus Nephritis: New and Emerging Biologic and Targeted Therapies
    Ajinath Kale, Maciej Lech, Hans‐Joachim Anders, Anil Bhanudas Gaikwad · 2023 · BioDrugs
  54. Effect of antimalarials on clinical outcomes in lupus nephritis
    Óscar R. Pena-Vizcarra, María Fernanda Zavala-Miranda, Bernardo Juarez Cuevas, Sofía E. Márquez-Macedo, Adriana Hernández-Andrade, Alberto Nordmann-Gomes, Abril A. Pérez-Arias, Luis Eduardo Morales-Buenrostro, Juan Manuel Mejia-Vilet · 2023 · Rheumatology
  55. Population-based incidence and time to classification of systemic lupus erythematosus by three different classification criteria: a Lupus Midwest Network (LUMEN) study
    Alí Duarte‐García, Mehmet Hocaoǧlu, Shirley‐Ann Osei‐Onomah, Jesse Y. Dabit, Rachel E. Giblon, Charles G. Helmick, Cynthia S. Crowson · 2021 · Lara D. Veeken
  56. Response to: ‘Correspondence on ‘Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities’’ by Rönnelid et al
    Sindhu R. Johnson, Martin Aringer · 2020 · Annals of the Rheumatic Diseases
  57. Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases
    Lou Deneuville, Arthur Mageau, Marie‐Pierre Debray, Karim Sacré, Nathalie Costedoat-Chalumeau, Eric HACHULLA, Y. Uzunhan, Erwan Le Tallec, Jacques L. Cadranel, Sylvain Marchand-Adam et al. · 2024 · Respirology
  58. Procalcitonin: Infection or Maybe Something More? Noninfectious Causes of Increased Serum Procalcitonin Concentration: Updated Knowledge
    Szymon Mućka, Grzegorz K. Jakubiak, Natalia Pawlas · 2025 · Life
  59. Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus
    Panagiotis Garantziotis, Lorenzo Beretta, Julius Lindblom, Georgia-Savina Moysidou, Dionysis Nikolopoulos, Ricardo Grieshaber‐Bouyer, Melanie Hagen, Christina Bergmann, Andreas Wirsching, Aline Bözec et al. · 2025 · Annals of the Rheumatic Diseases
  60. Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare
    Dina Zucchi, Chiara Tani, Elena Elefante, Chiara Stagnaro, Linda Carli, Viola Signorini, Francesco Ferro, Francesca Trentin, Giovanni Fulvio, Chiara Cardelli et al. · 2021 · PLoS ONE
  61. Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia
    Yan-Xia Zhan, Luya Cheng, Boting Wu, Li-Li Ji, Pu Chen, Feng Li, Jing-Jing Cao, Yang Ke, Ling-Yan Yuan, Z. Min et al. · 2021 · Annals of Translational Medicine
  62. The Categorization of Pain in Systemic Lupus Erythematosus
    David S. Pisetsky, Amanda M. Eudy, Megan E. B. Clowse, Jennifer L Rogers · 2021 · Rheumatic Disease Clinics of North America
  63. Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome
    Ilir I. Cinoku, Kleio‐Maria Verrou, Evangelia P. Piperi, Michael Voulgarelis, Haralampos Μ. Moutsopoulos, Clio P. Mavragani · 2021 · Journal of Autoimmunity
  64. Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
    Sinah Engel, Simone Cosima Boedecker-Lips, Paul Christoph Claßen, Stefan Bittner, Falk Steffen, Arndt Weinmann, Andreas Schwarting, Frauke Zipp, Julia Weinmann‐Menke, Felix Luessi · 2021 · Therapeutic Advances in Neurological Disorders
  65. Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study
    Qian-qian Liao, Yazhou Ren, Kewei Zhu, D. Qin, Yan-Ju Mo, S. Cong, Juan Wu, Chun-Ying Wang, Xiao-Jiao Cui, Hong-Zhen Xu et al. · 2022 · Frontiers in Immunology
  66. Diagnostic test accuracy of novel biomarkers for lupus nephritis—An overview of systematic reviews
    Juliana de Andrade Rebouças Guimarães, Silvânia da Conceição Furtado, Ana Cyra dos Santos Lucas, Bruno Mori, José Fernando Marques Barcellos · 2022 · PLoS ONE
  67. Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype
    MacIntosh Cornwell, Hanane El Bannoudi, Elliot S Luttrell-Williams, Alexis Engel, Tessa J. Barrett, Khrystyna Myndzar, Peter Izmirly, Michael H Belmont, Robert M. Clancy, Kelly V. Ruggles et al. · 2023 · Journal of Translational Medicine
  68. Should ACR/EULAR criteria be revised changing the RF and ACPA scores?
    G.E. Steiner, Lieve Van Hoovels, Dóra Csige, Mariele Gatto, Annamaria Iagnocco, Zoltán Szekanecz · 2023 · Autoimmunity Reviews
  69. Unveiling Ocular Manifestations in Systemic Lupus Erythematosus
    Mutali Musa, Ekele Chukwuyem, Oluwasola Michael Ojo, Efioshiomoshi Kings Topah, Leopoldo Spadea, Carlo Salati, Caterina Gagliano, Marco Zeppieri · 2024 · Journal of Clinical Medicine
  70. Early initiation of hydroxychloroquine in cutaneous lupus erythematosus to prevent progression to systemic lupus erythematosus: A long-term follow-up study
    Danielle Bar, Sharon Baum, Zvi I. Segal, Aviv Barzilai, Amit Druyan, Merav Lidar · 2025 · Journal of the American Academy of Dermatology
  71. A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis
    Paul Hoover, Chirag Raparia, David Lieb, Yochay Tzur, Joyce B. Kang, Arnon Arazi, Rollin Leavitt, Rakesh Mishra, Sujal I. Shah, Daimon P. Simmons et al. · 2025 · The Journal of Experimental Medicine
  72. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus
    Eman A. Hafez, Sameh Abd El-Mottleb Hassan, Mohammed Abd El Monem Teama, Fatma Mohammed Badr · 2020 · Lupus
  73. Neutrophil-to-lymphocyte ratios and platelet-to-lymphocyte ratios in juvenile systemic lupus erythematosus: correlation with disease manifestations.
    Wen-Gen Li, Su-Dong Liu, Chao Chen, Yanying Han · 2021 · Annals of Palliative Medicine
  74. Ability to Participate in Social Activities of Rheumatoid Arthritis Patients Compared with Other Rheumatic Diseases: A Cross-Sectional Observational Study
    Laura Cano‐García, Natalia Mena Vázquez, Sara Manrique Arija, Roció Redondo‐Rodríguez, Carmen María Romero-Barco, Antonio Fernández‐Nebro · 2021 · Diagnostics
  75. Subacute cutaneous lupus erythematosus induction after SARS‐CoV‐2 vaccine in a patient with primary biliary cholangitis
    Corrado Zengarini, Alessandro Pileri, Francesco Paolo Salamone, Bianca Maria Piraccini, Giovanni Vitale, M. La Plaça · 2021 · Journal of the European Academy of Dermatology and Venereology
  76. Rapid Biomarker-Based Diagnosis of Fibromyalgia Syndrome and Related Rheumatologic Disorders by Portable FT-IR Spectroscopic Techniques
    Siyu Yao, Haona Bao, Shreya Madhav Nuguri, Lianbo Yu, Zhanna Mikulik, Michelle M. Osuna-Diaz, Katherine Sebastian, Kevin V. Hackshaw, LUIS E. RODRIGUEZ‐SAONA · 2023 · Biomedicines
  77. Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study
    Cai Yue, Jian Jia Su, Xiaohong Fan, Song Li, Wei Jiang, Jinghua Xia, Tao Shi, Xuan Zhang, Xuemei Li · 2020 · Orphanet Journal of Rare Diseases
  78. Frequency of Polyautoimmunity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus
    M. C. Ordoñez-Cañizares, Natalia Mena Vázquez, Roció Redondo‐Rodríguez, Sara Manrique Arija, Francisco Gabriel Jiménez-Núñez, Inmaculada Ureña Garnica, Antonio Fernández‐Nebro · 2020 · JCR Journal of Clinical Rheumatology
  79. Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis
    Xiaohong Zhao, Qiong Wen, Yagui Qiu, Fengxian Huang · 2020 · Rheumatology International
  80. Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine
    Valentina Canti, Margherita Scarrone, Rebecca DE LORENZO, Giuseppe Alvise Ramirez, Roberta Erra, Sara Bordoli, Sara Cella, Elena Schmit, Susanna Rosa, Maria Teresa Castiglioni et al. · 2021 · Immunological Medicine
  81. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores
    Margitta Worm, Miriam Zidane, Lisa Eisert, Rebecca Fischer‐Betz, Ivan Foeldvari, Claudia Günther, Christof Iking‐Konert, Alexander Kreuter, Ulf Müller‐Ladner, Alexander Nast et al. · 2021 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
  82. Comparison of current methods for <scp>anti‐dsDNA</scp> antibody detection and reshaping diagnostic strategies
    Infantino, Maria, Palterer, Boaz, Previtali, Giulia, Alessio, Maria‐Grazia, Villalta, Danilo, Carbone, Teresa, Platzgummer, Stefan, Paura, Giusi, Castiglione, Caterina, Fabris, Martina et al. · 2022 · Scandinavian Journal of Immunology
  83. Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment
    Carolina Muñoz‐Grajales, Michelle L. Barraclough, Juan Pablo Díaz-Martínez, Jiandong Su, Kathleen S. Bingham, Mahta Kakvan, Roberta Pozzi Kretzmann, Maria Carmela Tartaglia, Lesley Ruttan, May Y. Choi et al. · 2024 · Frontiers in Immunology
  84. Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes
    Alexandros G. Panagiotopoulos, Eleni Kapsia, Ioannis Michelakis, John Boletis, Smaragdi Marinaki, Petros Paul Sfikakis, Maria G. Tektonidou · 2024 · Lara D. Veeken
  85. A retrospective evaluation of glucagon-like peptide-1 receptor agonists in systemic lupus erythematosus patients
    Philip M. Carlucci, Brooke Cohen, Amit Saxena, Michael H Belmont, Mala Masson, Heather Taffet Gold, Jill P. Buyon, Peter Izmirly · 2024 · Lara D. Veeken
  86. Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
    Katerina Chavatza, Myrto Kostopoulou, Dionysis Nikolopoulos, Ourania Gioti, K. Togia, Laura Andréoli, Martin Aringer, John Boletis, Andrea Doria, Frédéric Houssiau et al. · 2021 · Annals of the Rheumatic Diseases
  87. First Diagnosis of Systemic Lupus Erythematosus in Hospitalized Patients: Clinical Phenotypes and Pitfalls for the Non-Specialist
    Noemin Kapsala, Dionysis Nikolopoulos, Sofia Flouda, Aikaterini P. Chavatza, Dimitrios D. Tseronis, M. Aggelakos, Pelagia Katsimbri, George K Bertsias, Antonis Fanouriakis, Dimitrios T. Boumpas · 2021 · The American Journal of Medicine
  88. Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine
    Iris TIENLYNN. Lee, Lisa Zickuhr, Lynn Marisa Hassman · 2021 · Current Opinion in Ophthalmology
  89. Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodies
    Juan Irure‐Ventura, Marcos López‐Hoyos · 2022 · Journal of Translational Autoimmunity
  90. Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosus
    Martin Aringer, Karen H. Costenbader, Sindhu R Johnson · 2022 · Expert Review of Clinical Immunology
  91. Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis
    Giovanni Maria Rossi, Umberto Maggiore, Francesco Peyronel, Paride Fenaroli, Marco Delsante, Giuseppe Daniele Benigno, Davide Gianfreda, Maria Letizia Urban, Zerai G. Manna, Lois Johanna Arend et al. · 2022 · Kidney International Reports
  92. Artificial neural network - an effective tool for predicting the lupus nephritis outcome
    Jakub Stojanowski, Andrzej Konieczny, Klaudia Rydzyńska, Izabela Kasenberg, Aleksandra Mikołajczak, Tomasz Gołębiowski, Magdalena Krajewska, Mariusz Andrzej Kusztal · 2022 · BMC Nephrology
  93. Evaluating performance of the 2019 EULAR/ACR, 2012 SLICC, and 1997 ACR criteria for classifying adult-onset and childhood-onset systemic lupus erythematosus: A systematic review and meta-analysis
    Butsabong Lerkvaleekul, Pantira Chobchai, Sasivimol Rattanasiri, Soamarat Vilaiyuk · 2022 · Frontiers in Medicine
  94. Lupus spectrum ambiguity has long-term negative implications for patients
    Ian N Bruce, Joy N. Jones Buie, Lauren Bloch, Sang‐Cheol Bae, Karen H. Costenbader, Roger A. Levy, Victoria P. Werth, Ashley Marion, Sanjyot Sangodkar, Susan Manzi · 2023 · Lupus Science & Medicine
  95. Systemic lupus erythematosus disease activity and neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: a cross-sectional case–control study
    Safaa Abdalhadi, Naram Khalayli, Basel Al-Ghotani, Maysoun Kudsi · 2023 · Annals of Medicine and Surgery
  96. Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus
    Jérôme Granel, Helder Fernandes, Brigitte Bader‐Meunier, Amandine Guth, Olivier Richer, Pascal Pillet, Guy Leverger, Stéphane Ducassou, Mony Fahd, Marlène Pasquet et al. · 2024 · Blood
  97. Macrophages communicate with mesangial cells through the CXCL12/DPP4 axis in lupus nephritis pathogenesis
    Weiwei Li, Chun Yao, Haixia Guo, Xi’an Ni, Ran Zhu, Yongjun Wang, Bin Yu, Xuebing Feng, Zhifeng Gu, Zhanyun Da · 2024 · Cell Death and Disease
  98. Serum long noncoding RNAs FAS-AS1 & PVT1 are novel biomarkers for systemic lupus erythematous
    Marwa A. Ali, Olfat Gamil Shaker, Abeer A. Khalefa, MY Abdelwahed, EGI Ali, Eman Ezzat, HA Elghobary, Aeshah A. Awaji, NA Fouad, SE Ayoub · 2020 · British Journal of Biomedical Science
  99. COVID-19 in a patient with a flare of systemic lupus erythematosus: A rare case-report
    Abdulrahman Mishaal Alharthy, Fahad Ali Faqihi, Nasir Nasim, Alfateh Sayed Nasr Noor, Saima Akhtar, Ahmed N. Balshi, Abdullah Balhamar, Saleh A. Alqahtani, Ziad Ahmed Memish, Dimitrios Karakitsos · 2020 · Respiratory Medicine Case Reports
  100. The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity
    Yanli Zeng, Yan Zhang, Yiqiang Lin, Xuelian Wang, Qinggui Chen, Qinghe Huang, JiaJia Wang, Longcan Jiang, Yun Xiao · 2021 · Clinical and Experimental Medicine